Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology designed to optimize drug delivery for applications with significant unmet need, ...

Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third ...

Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis ...

Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing CapacityStirling, Scotland, 30 April 2025: Symbiosis Pharmaceutical Services (Symbiosis), ...

Clario, a leading provider of digital endpoint data solutions to the clinical trial industry today announced completion of its acquisition of WCG's electronic clinical outcome assessment (eCOA) ...

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision ...

Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fu ...

Informed consent is a foundational element of every clinical trial. Yet, the traditional paper-based process has long been ...

Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.

Kahler and Stetz bring deep leadership, operational, financial and strategic expertise to the Board as Tharimmune advances key clinical programs, executes on growth initiatives and strengthens ...

Learn how early Alzheimer's diagnosis and new treatments transformed life for patient George Carlino and his family.